Crossmark

Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib

Crossref DOI link: https://doi.org/10.1016/j.ejphar.2020.173238

Published Print: 2020-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Emori, Takashi

Kasahara, Michiko

Sugahara, Shingo

Hashimoto, Motomu

Ito, Hiromu

Narumiya, Shuh

Higashi, Yasuyuki

Fujii, Yasutomo
Funding

Funding for this research was provided by:

Astellas Pharma

Mitsubishi Tanabe Pharma Corporation
License Information

Text and Data Mining valid from 2020-09-01

Text and Data Mining valid from 2020-09-01

Version of Record valid from 2020-06-22
More Information

This article is maintained by: Elsevier

Article Title: Role of JAK-STAT signaling in the pathogenic behavior of fibroblast-like synoviocytes in rheumatoid arthritis: Effect of the novel JAK inhibitor peficitinib

Journal Title: European Journal of Pharmacology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ejphar.2020.173238

Content Type: article

Copyright: © 2020 The Authors. Published by Elsevier B.V.

Document is current

Any future updates will be listed below